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Eosinophilia is a characteristic feature of certain parasite infections and allergic 
conditions in which eosinophiis may be involved in the elimination of the parasite, 
and in the production of tissue damage. In most of these cases, the occurrence 
of eosinophils is selective, suggesting that mechanisms must exist to regulate the 
production of these cells independently of other members of the granulocyte- 
macrophage series. 
The mechanism of induction of selective eosinophilia is not known. Colony- 
stimulating factors (CSFs) l have been shown (1, 2) to regulate the proliferation, 
differentiation, and functional activation of hematopoietic cells, including eosin- 
ophils. One of the most important properties of CSFs is their lineage specificity. 
Thus, in the mouse, macrophage-CSF (M-CSF) (3) and granuiocyte-CSF (G-CSF) 
(4, 5) act predominantly on the monocyte-macrophage and neutrophil lineages, 
respectively. Granulocyte-macrophage CSF (GM-CSF) (5-7) acts on both of these 
lineages,  and  at  high  concentrations also  stimulates  the  growth  of eosinophil 
colonies. In man, analogs of the murine GM-CSF have been described, either as 
semipurified CSF-a (8), or as purified recombinant GM-CSF (9), and have been 
shown to stimulate neutrophil, eosinophil, and macrophage progenitors (8-10), 
as  well as  mature neutrophils and eosinopbils (1 1,  10).  The  human analog of 
murine G-CSF is probably CSF-/3,  which has been semipurified and biologically 
characterized (12). 
Hitherto there  have  been  no descriptions of a  purified eosinophil-CSF (Eo- 
CSF) from human or murine sources. Conditioned media from PWM-stimulated 
murine  spleen  cells  (spleenocyte-conditioned  medium;  SCM)  (13)  and  from 
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murine alloreactive T  cell clones (14) have been shown to cause proliferation of 
human  eosinophil  progenitors.  SCM  also  enhanced  the  metabolic  activity  of 
mature eosinophils (15). However, these conditioned media did not support the 
growth of murine eosinophils in the colony-forming assay in agar (13). 
The recent isolation of a  mouse T  cell hybrid line (NIMP-TH1) selected for 
the production of a  lymphokine with eosinophil differentiation activity without 
concomitant production of IL-2, IL-3, IFN-3,, G-CSF, or GM-CSF (16,  17), and 
the  subsequent  purification of the molecule, termed eosinophil  differentiation 
factor (EDF), have enabled us to examine whether this murine lymphokine has 
the properties expected of an Eo-CSF. In this paper, we show that murine EDF 
selectively  stimulated  the  clonal  proliferation  and  differentiation  of  murine 
eosinophil  progenitors,  establishing  this  molecule as  an  Eo-CSF.  In  addition, 
murine EDF stimulated the growth of human eosinophii progenitors and selec- 
tively  activated  mature  human  eosinophils  but  not  neutrophils  in  functional 
assays.  Thus  the  existence of a  murine  eosinophil-specific growth  regulator is 
established, and the data strongly suggest that there is a human analog of murine 
EDF (Eo-CSF). 
Materials and Methods 
Preparation of  EDF and Other Hematopoietic Growth Factors.  Purified EDF was prepared 
from conditioned media from the T cell hybrid line (NIMP-TH 1) (16, 17) by the following 
steps: ammonium sulfate precipitation, elution from a lentil lectin column, chromatogra- 
phy  on  phenyI-Sepharose  CL-4  B,  gel  filtration  on  AcA54-Sepharose,  ion-exchange 
chromatography on DEAE-Sepharose, followed by reverse-phase chromatography on a 
C~s-bondapak  column.  The full details of the purification procedure will be published 
elsewhere. The degree of purification was estimated to be  10,000-fold, and the activity 
titrated to a dilution of 1:10,000 in the mouse liquid bone marrow culture system (17). 
In every series of experiments, purified EDF was used. In few individual experiments, 
crude N IMP-THl-conditioned medium, which we have shown previously (17) contains 
only EDF, was used; no differences were ever found whether the purified material or 
NIMP-TH 1-conditioned medium was employed. 
The  other  hematopoietic  growth  factors  used  were  human  placental-conditioned 
medium (HPCM) (8), conditioned medium from the human bladder carcinoma cell line 
(U5637) (BCM), and semipurified CSF-a and -fl obtained after fractionation of the latter 
by hydrophobic chromatography (12).  These were generously provided by Dr.  N.  A. 
Nicola, Walter and Eliza  Hall Institute of Medical Research.  Mouse lung-conditioned 
medium (MLCM) was obtained as serum-free medium conditioned for 48 h  by whole- 
lung tissue from mice injected with endotoxin (18).  Mouse SCM was obtained by stimu- 
lating  spleen  cells  from  BALB/c  mice  with  PWM  as  previously described  (13).  All 
preparations of CSF were pretitrated and diluted to deliver a supramaximal stimulus. No 
preparation exhibited high-dose inhibition. 
Animals.  Inbred C57BL and CBA mice were maintained in the Walter and Eliza Hall 
Institute animal facility. 
Human Bone Marrow  Cells.  In  accordance with a  protocol approved by the  Ethics 
Committee of The  Walter  and  Eliza  Hall  Institute,  human  bone  marrow  cells  were 
obtained from individuals undergoing cardiac surgery who had no hematological disorder. 
Cells were layered on Ficoll/Hypaque (1.077 g/ml) (Pharmacia Fine Chemicals, Uppsala, 
Sweden) and centrifuged for 20 rain at 1,000 g. The cells were washed and resuspended 
in lscove's Modified Dulbecco's Medium (IMDM) (Gibco, Grand Island, NY) containing 
10% FCS (Flow Laboratories, North Ryde, New South Wales, Australia). 
Bone Marrow Cultures.  The colony assay used was as previously described (1), with few 
modifications. Stimuli (0.1 ml) were placed in 35-mm tissue culture dishes to which murine LOPEZ  ET  AL.  1087 
or human hematopoietic progenitor cells were added in 1 ml mixtures of double-strength 
IMDM, FCS, and 0.6%  Bacto-agar (Difco Laboratories,  Detroit,  MI.) in the ratio  3:2:5 
vol/vol/vol. C57BL bone  marrow  cells  or CBA  12-d  fetal  liver  cells  were  cultured  at 
concentrations of 7.5  x  I04 cells/ml  and  3  x  104 celis/ml,  respectively.  Human  bone 
marrow cells were cultured at 2-5 x  104 cells/ml. Cultures were incubated at 37°C in a 
humidified atmosphere of 10%  CO2 in air for 7-16 d. Colonies (clones containing ~>50 
cells)  were counted  using a  dissection  microscope and  were morphologically identified 
after glutaraldehyde fixation of the entire culture,  followed by staining with Luxol Fast 
Blue and Meyer's hematoxylin. 
Clone Transfer Experiments.  Developing clones from cultures  initiated  in  EDF  were 
picked off individually using a  fine Pasteur pipette and transferred  in groups of five to 
the surface of agar-medium in a second culture dish containing different stimuli. Transfers 
were made after 7 d of incubation, and the cells were incubated for a further 9 d. Clone 
size was recorded at both of these points, and clones that had at least doubled in size were 
picked off and fixed and stained for morphological identification as described above. 
Purification of Human  Granulocytes.  Peripheral  blood  from  normal  volunteers  was 
sedimented on dextran, and the leukocyte-rich supernatant was centrifuged on a discon- 
tinuous  gradient  of hypertonic  Metrizamide  (Nyegaard,  Oslo,  Norway) as  previously 
described (19). The eosinophi[ and neutrophil preparations  were always >90 and >95% 
pure, respectively. Unless otherwise stated, granulocytes were suspended in Eagle's MEM 
(Flow Laboratories) containing 10% FCS and antibiotics (benzylpenicillin 60 rag/liter and 
streptomycin  100 rag/liter)(Glaxo,  Boronia, Victoria, Australia). 
ADCC Assay.  This was carried  out using as targets 5~Cr-labelled  P815 cells coupled 
with TNP as previously described (11). Briefly, 40 ~1 P815 cells (4 ×  103) were incubated 
in  V-bottom  microtiter  plates  (Linbro;  Flow  Laboratories,  McLean,  VA)  with  24  ~1 
crossreacting rabbit IgG anti-DNP (Miles-Yeda,  Rehovot, Israel),  16 #1 stimulus, and 80 
ul human eosinophils or neutrophils (1.3 ×  105) as effector cells. After incubation for 2.5 
h at 37 ° C, 80 #1 supernatant was removed and assayed in a ~,-counter. Percent cytotoxicity 
was determined according to the formula:  100 ×  (test -  control)/(total -  control), where 
control was the  ~tCr released  by P815 in the  presence of medium alone,  and total  the 
'~Cr released by the addition of 5% Triton X-100. The results shown are the means of 
triplicate determinations. 
Phagocytosis Assay.  This  assay  used  heat-killed  baker's  yeast and  was performed  as 
previously described (20) and modified (10).  Purified eosinophils or neutrophils (100 ul; 
2  ×  l0 T celts/ml  in  PBS)  were  incubated  with  250  #1  yeast  organisms,  100  #1  fresh 
autologous serum, and 50 t~] EDF, BCM, or medium for 1 h at 37°C. The cells were then 
centrifuged at 4°C, resuspended in 50 t~l cold saline, and smears were made before mixing 
in methanol  and  staining  with  Giemsa.  The smears were examined  for the number of 
eosinophils or neutrophils showing different numbers of phagocytosed yeast, and the data 
are expressed  as the percentage of cells containing different numbers of phagocytosed 
organisms by counting a minimum of 200 cells on each of three replicate slides. 
Immunofluorescence Assay.  Purified  human  eosinophils  were  made  up  to  2  ×  106 
cells/ml and 400 gl aliquots (8 ×  10  ~ cells) were incubated with 80 ~1 EDF, CSF-a, FMLP 
(Sigma Chemical Co., St. Louis, MO), LPS (011 :B4, Sigma Chemical Co.) or medium for 
1 h at 37 o C. The cells were then washed and incubated (2 ×  10  h cells/tube) with different 
mAb for  1 h  at 4°C. The mAb used were: WEM-G1  (21),  WEM-G11  (22), and OKM1 
(23) (Ortho-mune Diagnostic, Melbourne, Victoria, Australia) directed against functional 
antigens on human granuiocytes, anti-O2-microglobulin (t32m) (IgG2b anti-/~m, gift from 
Dr.  I. F. C. McKenzie, Dept. of Pathology, Univ. of Melbourne, Australia), and also K7 
(IgM anti-TNP, gift from Dr. G. Klauss, National Institute for Medical Research, London) 
and PB 10 (IgG1 against the chicken 0 antigen, gift from Dr. P. Bartlett, Walter and Eliza 
Hall Institute of Medical Research) as control mAb that do not bind to granuiocytes. With 
the exception of OKM 1, the mAb were directly conjugated with FITC (24).  In the case 
of OKM 1, eosinophils were further incubated with goat anti-mouse Ig-FITC (Tago Inc., 
Burlingame,  CA).  After  incubation  the  cells  were  washed  three  times  and  fixed  as 
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TABLE  I 
Morphology of Mouse Colonies Stimulated by EDF 
Colonies  Colonies per  Type of colony (%) 
Exp.  Ceils  Stimulus  typed  10  5 cells  Eo  G  GM  M 
1  Bone 
marrow 
2  Bone 
iTlarrow 
3  Bone 
marrow 
EDF  6  2  100  0  0  0 
SCM  50  180  4  20  41  35 
MLCM  50  201  2  14  51  33 
EDF  5  2  100  0  0  0 
SCM  50  180  2  5  44  49 
MLCM  50  177  1  5  37  57 
EDF  9  3  100  0  0  0 
SCM  50  180  2  5  47  46 
MLCM  50  160  3  3  40  54 
4  Fetal  EDF  14  12  100  0  0  0 
liver  SCM  50  280  1  1  36  62 
MLCM  50  149  8  0  38  54 
5  Fetal  EDF  17  14  100  0  0  0 
liver  SCM  50  337  7  9  43  41 
MLCM  50  175  10  7  40  43 
6  Fetal 
liver 
EDF  16  13  84  11  0  5 
SCM  50  274  2  2  36  60 
MLCM  50  152  2  5  43  50 
Quadruplicate  plates containing  7,5 x  104 C57BL bone marrow or 3  X  104 CBA fetal liver cells were 
incubated  for 7 d  with EDF, SCM, or MLCM. After counting  the number of colonies on each plate, 
they  were  fixed  and  stained  for  morphological  typing.  Where  <50  colonies  were  obtained,  all  of 
them were scored. Purified  EDF was used in exps.  3, 4, and 5, whereas in the others, EDF-containing 
NIMP-TH 1-conditioned  medium  was used. 
Flow Cytometry.  Fixed eosinophils were analyzed in a FACS (FACS II; Becton-Dickin- 
son  Immunocytometry  Systems,  Mountain  View,  CA)  equipped  with  a  three-decade 
logarithmic  amplifier  in  the  fluorescence  detection  channel  and  linked  to  a  PDPll 
computer data-handling system.  In each sample,  more than  9,000  cells were analyzed. 
The coefficient of variation of the analysis by the FACS  II  was <3%.  After computer 
transformation to a linear scale, the mean and median fluorescence of each sample were 
calculated. The mean was defined as the sum of the fluorescence intensities of individual 
cells  divided  by  the  number  of  cells  analyzed,  and  the  median  was  defined  as  the 
fluorescence below which 50% of the cells were found. 
Results 
Selective  Stimulation  of Mouse  Eosinophil  Colonies  by  EDF.  To  determine 
whether  EDF  could  stimulate  the  clonal  proliferation  and  differentiation  of 
murine eosinophil  progenitors  in  semisolid  agar  cultures,  mouse bone  marrow 
and fetal liver cells were cultured in the presence of EDF and other CSFs.  It was 
found  (Table  I)  that  EDF  generated  small  numbers  of  eosinophil  colonies 
containing at least 200  cells after  7  d  of culture of both bone marrow and fetal 
liver cells. In most experiments, EDF stimulated only eosinophil colonies, whereas 
the expected  proportions  of neutrophil  (G),  neutrophil-macrophage  (GM),  and LOPEZ  ET  AL.  1089 
macrophage  (M) colonies developed in  the presence of SCM and of MLCM; a 
source of G- and GM-CSF (Table I). When the results of the three experiments 
using bone marrow cells and fetal liver cells were pooled, it was found that all 
20 and 44 of 47 colonies stimulated by EDF were eosinophilic. Furthermore, the 
absolute number of eosinophil colonies stimulated by EDF was similar to those 
obtained with SCM and MLCM, suggesting that EDF stimulates the proliferation 
of all  responsive  eosinophil  progenitor  cells.  At high  concentrations  EDF also 
stimulated some G, GM, and M clusters (3-49 cells per clone), suggesting that it 
may have some activity on these lineages (data not shown).  Notwithstanding  a 
degree of crossreactivity, these data indicate that EDF is a  murine Eo-CSF, and 
they  are  of considerable  interest  since  this  had  not  been  observed  with  the 
human-active Eo-CSF present in SCM (13). 
EDF Selectively Stimulates Growth of Eosinophils from Human Bone Marrow.  In 
experiments examining the ability of EDF to stimulate human bone marrow cells 
to  form  colonies  in  agar,  only  day  14  colonies  were  obtained.  The  absolute 
number of clones was less than  that stimulated by CSF-a (the human analog of 
murine GM-CSF) or HPCM, but was similar to the numbers of colonies stimulated 
by murine  SCM (Table II).  Morphological examination  of the day  14 colonies 
stimulated by EDF showed that these were almost exclusively eosinophil in type 
(Fig.  1), whereas CSF-a and HPCM also stimulated the formation of G, GM, and 
M colonies. In exp. 3 (Table II), a few macrophage colonies were seen in cultures 
stimulated by EDF, but these were also seen in unstimulated  cultures (data not 
shown), suggesting that they arose spontaneously in this particular bone marrow 
sample. In any one experiment, the total number of eosinophil colonies induced 
by EDF was similar to that found with EDF, SCM, CSF-a, or HPCM, suggesting 
that EDF was stimulating all eosinophil progenitor cells and not simply a subset 
of these, a conclusion supported by the observation that the eosinophil colonies 
stimulated by EDF and HPCM were of similar size (Fig. 2). 
Direct Effect of EDF on Eosinophil  Progenitor  Cells.  The proliferative effect of 
murine EDF on human  cells and the higher frequency of clonogenic eosinophii 
precursors  in  human  bone  marrow  enabled  further  studies  on  the  actions  of 
EDF. To confirm that the stimulation of eosinophil colonies was a direct effect 
of EDF and  not mediated via an accessory cell, two types of experiment  were 
performed. First, human bone marrow cells were cultured at varying concentra- 
tions,  and  it  was  shown  that  the  relationship  between cell  concentration  and 
number of eosinophil colonies stimulated by EDF was linear. The concentration 
of cells cultured ranged  from 0.0625-2.0  x  105 ceils/ml,  and  the numbers of 
colonies stimulated were between 0.5 +  0.5 and  16.7 _  1.2 (mean +  SD). 
The  second type of experiment  involved clone transfers.  Bone marrow  cells 
were  initially  stimulated  by EDF  for  7  d  in  primary  culture,  and  developing 
clones (mean  15 cells per clone) were then transferred to recipient culture dishes 
containing either EDF, CSF-0~, or medium. This transfer results in a dilution of 
the initiating  CSF by a  factor of 1:500,  and allows an assessment of the direct 
effect of CSF in cultures lacking other cell types (26). Following a further 9 d of 
incubation, a significant proportion of the transplanted clones showed a progres- 
sive  increase  in  size  in  cultures  containing  EDF  and  CSF-a,  whereas  clones 
decreased in  size and  died when  transferred  to cultures  lacking  CSF (Fig.  3). 1090  EOSINOPHIL  COLONY-STIMULATING  FACTOR  IN  MAN 
TABLE  II 
Morphology of Human Bone Marrow Colonies Stimulated by EDF 
Exp.  Stimulus  Colonies per  Type of colony (%)  Calculated num- 
plate*  Eo  G  GM  M  ber of Eo colonies 
EDF  13  100  0  0  0  13 
CSF-a  36  39  0  44  17  14 
HPCM  23  19  0  45  36  4 
EDF  10  100  0  0  0  10 
CSF-a  38  33  0  28  39  13 
HPCM  50  12  0  44  44  6 
EDF  40  94  0  0  6  38 
SCM  38  98  0  0  2  37 
CSF-a  68  18  0  17  65  12 
HPCM  174  16  4  43  37  28 
EDF  63  100  0  0  0  63 
SCM  67  100  0  0  0  67 
HPCM  220  20  28  22  30  44 
EDF  12  100  0  0  0  12 
SCM  14  100  0  0  0  14 
CSF-a  78  22  7  17  54  17 
HPCM  108  22  25  19  33  24 
EDF  6  100  0  0  0  6 
SCM  4  100  0  0  0  4 
HPCM  54  14  41  24  22  8 
EDF  8  100  0  0  0  8 
SCM  25  81  0  0  19  20 
CSF-a  60  12  17  17  54  7 
HPCM  87  13  21  29  38  11 
EDF  8  100  0  0  0  8 
SCM  8  100  0  0  0  8 
CSF-a  34  23  7  30  40  8 
HPCM  42  26  21  23  30  11 
* Normal human bone marrow cells were incubated for 14 d and stimulated as indicated. The mean 
absolute number of colonies was determined by scoring four replicate cultures.  These cultures 
were then fixed and stained, and consecutive colonies were examined to determine the percentage 
of each colony type present. The number of cells cultured was 2-5 ×  10  4 cells/ml. Exps.  1-3 used 
EDF as NIMP-THl-conditioned medium, and Exps. 4-8 used purified EDF. 
The  proliferating  clones  were  confirmed  to  be  eosinophilic  in  type.  Three 
granulocyte-macrophage  clones  were  noted  to develop  from  clones  transferred 
to CSF-a,  however,  it was  not  possible  to attribute  the  initiation  of these  clones 
to EDF  because  of the  presence  of accessory  cells in the  primary  culture. 
Selective Activation of Human Eosinophil Function by EDF.  Several  parameters 
of functional  activation  were  measured  after  treatment  of mature  human  eosin- 
ophils  with  EDF.  EDF  was  firstly  tested  for  its  ability  to  stimulate  peripheral 
blood  eosinophils  and  neutrophils  in  an  ADCC  assay.  Eosinophils  showed  very LOPEZ  ET  AL.  1091 
FIGURE  1.  Typical  appearance of a  day  14  eosinophil colony  derived  from  human bone 
marrow cells stimulated with purified EDF. 
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FIGURE  2.  Histogram showing a comparison between the size of eosinophil colonies obtained 
by stimulating human bone marrow ceils with purified EDF (top) and HPCM (bottom). These 
data were obtained from exps. 4 and 5 shown in Table I1.65 consecutive eosinophil colonies 
were scored for both stimuli. 
low  levels  of ADCC  against  target  cells  in  the  absence  of EDF,  however,  the 
addition  of EDF  resulted  in  a  highly  increased  capacity  to  kill  target  cells  by 
eosinophils from all six individuals tested (Fig. 4). Neutrophils tested in parallel, 
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FIGURE 3.  Proliferation ofeosinophil clones 9 d after transfer of clones to cultures containing 
CSF-a (A), purified EDF (B), or medium (C). The broken and solid lines indicate maintenance 
or doubling of initial cell number, respectively. Clones which had at least doubled in size were 
confirmed to be eosinophilie (open circles). 
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cells. The squares show values obtained in the presence of medium, and the circles show values 
obtained in the presence of EDF  tested at a  final dilution of 1:10.  Four experiments were 
performed with EDF as NIMP-THl-conditioned medium, and two with purified EDF. 
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FIGURE  5.  Titration of purified EDF (open circles) on human eosinophil- and neutrophil- 
mediated ADCC. Titrations of CSF-a (closed circles) and CSF-J (open squares) are also shown. LOPEZ  ET  AL. 
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FIGURE 6.  Effect of purified EDF (open circles) in stimulating the phagocytosis of serum- 
opsonized yeast by human eosinophils but not neutrophils. The effects of BCM (closed circles) 
and medium (open squares) are also shown. 
1093 
In  contrast  to  EDF,  CSF-/3  did  enhance  ADCC  by  neutrophils  and  CSF-a 
stimulated both eosinophils and neutrophils (Fig. 5). 
Purified EDF was also found (Fig. 6) to selectively enhance eosinophil-mediated 
phagocytes of serum-opsonized yeast organisms. Very little phagocytosis was seen 
when  eosinophils  were  incubated  with  yeast  organisms  opsonized  with  2.5% 
human serum in the absence of EDF. However, the addition of EDF resulted in 
an increase in both the number of eosinophils showing internalized yeast particles, 
and  the  number  of yeast particles  internalized  per  eosinophil.  Again,  human 
neutrophils were not stimulated by EDF, although an increase in their phagocytic 
activity was evident when these cells were incubated with BCM. 
Enhancement of Functional  Granulocyte Antigen Expression by EDF.  The  acti- 
vation of neutrophils has been shown to be associated with an increased expres- 
sion  of membrane  antigens  such  as  granulocyte  functional  antigens  1  and  2 
(GFA-I and GFA-2) (25), and the receptor for C3bi (27) identified by the mAb 
WEM-G1,  WEM-G11,  and  OKM1  respectively.  To  determine  whether  EDF 
induced similar changes,  eosinophils were incubated with or without EDF, and 
the degree of binding of these mAb was tested. 
It was found (Table III) that the binding of WEM-G1, WEM-G11, and OKM 1 
to eosinOphils was greater after the cells had been incubated with EDF than after 
incubation with medium,  LPS, or FMLP. In three different experiments,  EDF 
enhanced the binding of WEM-G 1, WEM-G I 1, and OKM 1 from medium control 
levels by 48 _+ 11 (percent mean fluorescence increase _+ SE), 61  +  10 and 94 _+ 
11%,  respectively,  much  higher  than  the coefficient of variation  of the  FACS 
(<3%). An increase in binding was also observed with eosinophils preincubated 
with CSF-ct, but to a lesser extent than that seen with EDF. Essentially no change 
in the binding of the control antibodies anti-/39m,  KT, PB 10, or goat anti-mouse 
Ig was observed, suggesting that the effect was a specific event. 
To establish the relative amounts of EDF necessary to induce this enhancement 
of the expression of functional  antigens  on eosinophils, a  titration  was carried 
out. It was found (Fig. 7) that EDF increased the expression of GFA-1, GFA-2, 
and OKM1  in a  dose-dependent  manner,  and was specific since no increase in 
the expression of/32m or in nonspecific binding by mAb PB 10 was seen. 1094  EOSINOPHIL  COLONY-STIMULATING  FACTOR  IN  MAN 
TABLE  III 
Effects of EDF and Other Stimuli on Expression of Functional Antigens on Human Eosinophils 
mAb probe 
Stimulus* 
EDF*  CSF-a  FMLP  0  LPS  j  Medium 
WEM-G1  703  508  421  432  421 
WEM-G 11  57  48  47  46  44 
OKM1 +  goat anti-mouse Ig  100  90  58  58  57 
K7  20  20  20  20  19 
Anti-/32m  26  24  25  25  26 
PBI0  24  21  23  22  26 
(;oat anti-mouse lg  25  24  25  24  24 
* Median fluorescence intensity expressed in arbitrary units. The mean fluorescence values (+SEM) 
obtained with eosinophils from three different individuals and incubated with and without EDF 
were 722 +  95 and 492 +  63 for WEM-G1 (P <  0.05), 88 +  37 and 54 +  20 for WEM-G11  (not 
significant), and 172  +  22 and 89 __-  11  (p <  0.05) for OKM1. Note that the degree of WEM-G1 
and WEM-G11  binding is very different between individuals (37),  which leads to relatively high 
variations. 
* EDF was used as NIM-TH l-conditioned medium. 
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Discussion 
This paper shows that the murine lymphokine, eosinophil differentiation factor 
has all the properties of a human CSF with specificity for the eosinophil lineage. 
These properties include the ability to  stimulate the  clonal proliferation and 
differentiation of eosinophil progenitor cells, as well as the capacity to stimulate 
mature eosinophils.  In light of other examples of functional crossreactivity (5, 
!2,  28) and sequence homology (9)  between murine and  human CSFs,  these 
findings suggest the existence of a  human analog of EDF and should stimulate 
further efforts towards its characterization. They would also predict the existence 
of a functionally conserved receptor. 
The colony-stimulating activity of EDF on human bone marrow was demon- LOPEZ ET  AL.  1095 
strated after 14 d in culture. These colonies contained only eosinophils and were 
similar in  number to those eosinophil colonies resulting  from stimulating  with 
HPCM  or  CSF-o~. HPCM  and  CSF-a  also  induced  the  growth  of neutrophil, 
neutrophil-macrophage,  and macrophage colonies, as expected. The size distri- 
butions of the eosinophil colonies generated by EDF and HPCM were compara- 
ble, and  hence it is likely that  they act on the same responsive cells. That  this 
action  is due to the effect of EDF on the progenitor  cells was shown by clone 
transfer experiments, in which continuing clonal proliferation was stimulated by 
EDF  in  the  absence  of accessory cells,  and  by showing  a  linear  relationship 
between colony number and number of progenitor cells plated.  In other exper- 
iments  (our  unpublished  observations),  EDF,  in contrast  to CSF-a and  CSF-/3, 
was shown to preferentially  induce the growth of small  numbers of eosinophil 
clusters  from  bone marrow  fractions  highly  enriched  for promyelocytes, thus 
suggesting that eosinophil promyelocytes behave similarly to those of the neutro- 
phil lineage (29) in their ability to divide and in their potential to respond to a 
lineage-specific CSF. 
After differentiation  into mature,  postmitotic peripheral  blood cells, human 
eosinophiis retained their responsiveness to EDF. Assays for antibody-dependent 
killing and phagocytosis both showed enhancement with EDF. The specificity of 
this factor for eosinophils was conserved at the mature cell level, since neutrophils 
were unresponsive to EDF in both assays; neutrophils,  however, could be acti- 
vated by other stimuli such as CSF-a, CSF-/~, BCM. In addition,  we have found 
that EDF prolonged the survival in vitro of eosinophils but not neutrophils, while 
CSF-a increased the survival of both cell types (C.  G. Begley, A. F. Lopez, D. J. 
Warren, C.J. Sandersen, and M. A. Vadas, manuscript in preparation). 
The effect of EDF on phagocytosis could be explained in part by its ability to 
upregulate  the  C3bi receptor,  as shown by an increase in the binding of mAb 
OKM 1. This was accompanied by the augmented expression of two other surface 
antigens, GFA-1 and GFA-2, previously shown (21, 22) to be involved in several 
granulocyte functions. The specificity of this effect was indicated by the unaltered 
expression of/32m. The C3bi receptor (27), GFA-1 and GFA-2 (25) are selectively 
upregulated  on  activated  neutrophils.  This  is  the  first  description  of  their 
upregulation on activated eosinophils and their modulation by a growth factor. 
The  existence of a  human-active  murine  Eo-CSF was suggested  in  previous 
experiments, where it was shown that a factor present in conditioned media from 
mouse EL4 cells (30) and in murine SCM stimulated human  bone marrow (13) 
and  mature  eosinophils (15).  While the human-active  Eo-CSF in  SCM was not 
fully characterized,  it  was biochemically separable  from  murine  GM-CSF and 
purified multi-CSF (IL-3) also present in SCM (13);  both of which are inactive 
on  human  bone marrow  cells.  Purified  EDF  has also been distinguished  from 
GM-CSF  and  IL-3  (17).  Thus  it  is  possible  that  the  human-active  Eo-CSF 
previously described in SCM and the supernatants  of alioreactive T  cell clones 
may be identical to EDF. 
Hitherto it was thought that these human-active Eo-CSFs were inactive in the 
murine semisolid agar culture (13, 14), but in the present study it was found that 
under  optimal  culture  conditions  EDF  stimulated  the  formation  of  murine 
colonies, and that the colonies obtained were almost exclusively eosinophilic. At 1096  EOSINOPHIL  COLONY-STIMULATING  FACTOR  IN  MAN 
these concentrations of EDF,  however, clusters of granulocytes and/or macro- 
phages were also consistently stimulated in murine cultures, suggesting that EDF 
may also have some role in initiating other hematopoietic cell types, in keeping 
with other lineage-specific CSFs (1). 
The stimulation of mature granulocyte function by CSFs may have important 
implications  in  clinical  conditions  since  such  activation  may be  amenable  to 
exogenous control. At least in vitro, mouse GM-CSF and G-CSF have been shown 
to stimulate granulocyte function (5,  7).  Human monocyte-conditioned media 
(31, 32), semipurified CSF-a and semipurified CSF-/3 (11), and purified natural 
(33, 34) and purified recombinant GM-CSF (9,  10) have been found to enhance 
several neutrophit and eosinophil functions. Furthermore, the observation that 
patients with Schistosoma  mansoni infection develop eosinophilia and enhanced 
eosinophil-mediated killing suggests that an eosinophil-specific CSF may be at 
work in vivo (35).  Moreover, in experimental situations,  it was found that the 
injection of multi-CSF (IL-3) into mice induced the cell proliferation and acti- 
vation expected from its action in vitro (36), thus demonstrating the therapeutic 
potential of these molecules. 
The  specificity of mouse  EDF  (Eo-CSF)  for the eosinophil  lineage  in  man 
strongly  indicates  the  presence  of a  corresponding human  molecule and  its 
receptor,  thus  providing  a  mechanism  for  the  selective  eosinophila  seen  in 
helminth infections, allergic conditions and the hypereosinophilic syndrome. 
Summary 
A  purified murine lymphokine, eosinophil differentiation factor (EDF), was 
found to be a  selective stimulus for the clonal proliferation and differentiation 
of murine eosinophil progenitor cells, establishing it as the murine eosinophil 
colony-stimulating factor (Eo-CSF).  EDF was also active on human eosinophil 
progenitors and mature blood eosinophils, but had no effect on neutrophil or 
macrophage precursor cells, nor on blood neutrophils. In culture of human bone 
marrow  cells,  EDF  stimulated  equal  numbers  and  equal  sizes  of eosinophil 
colonies to develop when compared with human placental conditioned medium, 
a  source of human CSFs,  suggesting that all  responsive progenitor cells were 
stimulated.  Clone  transfer  experiments  and  the  linear  relationship  between 
number of bone marrow cells plated and colonies produced confirmed that the 
action of EDF  was directly on eosinophil progenitor cells.  EDF increased the 
capacity of human blood eosinophils, but not neutrophils, to kill antibody-coated 
tumor  cells and  to  phagocytose serum-opsonized yeast cells.  This  functional 
activation was associated with  the enhanced expression of functional antigens 
(GFA-1, GFA-2, and the receptor for C3bi) on eosinophils. 
The possession by EDF (Eo-CSF) of all the properties expected of a  human 
eosinophil CSF raises the possibility that a human analog of this molecule exists, 
and is involved in the regulation of production and function of human eosinophils 
in vivo. 
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